DNB
82
-2
CB
55
2
VTR
55
8
AAL
51
-3
NWSA
63
-4
EW
46
3
UHS
62
6
DUK
64
7
AKAM
50
-3
CTSH
60
3
BWA
48
-5
PFG
50
-2
O
24
2
FLR
56
-2
ADT
50
2
OKE
78
3
NVDA
54
2
SJM
45
9
DHI
52
-4
WY
60
-2
DNB
82
-2
CB
55
2
VTR
55
8
AAL
51
-3
NWSA
63
-4
EW
46
3
UHS
62
6
DUK
64
7
AKAM
50
-3
CTSH
60
3
BWA
48
-5
PFG
50
-2
O
24
2
FLR
56
-2
ADT
50
2
OKE
78
3
NVDA
54
2
SJM
45
9
DHI
52
-4
WY
60
-2
Financhill
Back

SPDR® S&P Capital Markets ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
85

KCE
SPDR® S&P Capital Markets ETF

Last Price:
147.85
Seasonality Move:
3.77%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.13
Seasonality Move:
14.88%
Buy
85
SPDR® S&P Capital Markets ETF (KCE) is a Buy

Is SPDR® S&P Capital Markets ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Capital Markets ETF [KCE] share price is $148.25. The Score for KCE is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
  • KCE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KCE Stock Price Chart

What is SPDR® S&P Capital Markets ETF's stock price today?

  • The SPDR® S&P Capital Markets ETF share price today is $148.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KCE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

KCE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.11 Buy
Relative Strength Index (14 RSI): 73.9 Buy
Chaikin Money Flow: 57926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (133.69 - 145.57) Buy
Bollinger Bands (100): (115.74 - 135.7) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

KCE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 145.42 Buy
20-day SMA: 141.24 Buy
50-day SMA: 133.81 Buy
200-day SMA: 117.11 Buy
8-day EMA: 145.82 Buy
20-day EMA: 142.01 Buy
50-day EMA: 135.08 Buy
200-day EMA: 118.85 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

SPDR® S&P Capital Markets ETF Earnings Growth & KCE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

SPDR® S&P Capital Markets ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):